(Q31108441)

English

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

scientific article

Statements

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials (English)
Dushyantha Jayaweera
Sabrina Spinosa-Guzman
POWER 1 and 2 study groups

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit